10-Q: Superior Group of Companies Reports Mixed Second Quarter Results Amidst Revenue Growth and Increased Expenses

Superior Group of Companies saw a slight increase in net sales but a decrease in net income for the second quarter of 2024, compared to the same period last year, while also reporting a material weakness in internal controls.

Summary

• Superior Group of Companies reported a 2.0% increase in net sales for the three months ended June 30, 2024, reaching $131.7 million, compared to $129.2 million in the same period of 2023.
• Net income for the quarter decreased to $0.6 million, or $0.04 per share, from $1.2 million, or $0.08 per share, in the second quarter of 2023.
• For the six months ended June 30, 2024, net sales increased by 4.1% to $270.6 million, compared to $259.9 million in the first half of 2023.
• The company's net income for the first six months of 2024 was $4.5 million, or $0.27 per diluted share, compared to $2.1 million, or $0.13 per diluted share, for the same period in 2023.
• The company's EBITDA was $5.6 million for the three months ended June 30, 2024, compared to $7.4 million for the same period in 2023.
• EBITDA for the six months ended June 30, 2024, was $15.2 million, compared to $14.3 million for the same period in 2023.
• The company's weighted average interest rate on outstanding borrowings was 6.4% as of June 30, 2024.
• The company had $78.5 million in outstanding borrowings under its credit facilities as of June 30, 2024.
• The company declared cash dividends of $0.14 per share for both the three and six month periods ended June 30, 2024.

Sentiment

Score: 5

Explanation: The document presents mixed results with some positive aspects like revenue growth and improved gross margins, but also negative aspects like decreased net income and a material weakness in internal controls. The overall sentiment is neutral to slightly negative.

Positives

• The company experienced a 4.1% increase in net sales for the six months ended June 30, 2024, reaching $270.6 million.
• Gross margin rates improved in the Branded Products and Healthcare Apparel segments.
• Interest expense decreased significantly due to lower outstanding borrowings and a lower weighted average interest rate.
• The company's net income for the first six months of 2024 was $4.5 million, compared to $2.1 million for the same period in 2023.
• The company has undrawn capacity of $114.0 million under its revolving credit facility as of June 30, 2024.

Negatives

• Net income decreased in the second quarter of 2024 compared to the same period in 2023.
• Selling and administrative expenses increased as a percentage of net sales.
• Healthcare Apparel net sales decreased by 5.3% in the second quarter of 2024.
• The company reported a material weakness in internal control over financial reporting related to its Contact Centers segment.
• The company's EBITDA decreased in the second quarter of 2024 compared to the same period in 2023.

Risks

• The company is exposed to risks related to changes in interest rates on its debt.
• Sales to customers outside of the United States are subject to fluctuations in foreign currency exchange rates.
• The company's manufacturing facilities and warehouses in Haiti are at risk of damage or disruptions from civil unrest.
• The company's ability to remediate its material weakness in internal control over financial reporting is ongoing.
• The company is subject to general economic and political conditions that may impact its business.

Future Outlook

Management believes that the combination of current cash levels, cash flows from operating activities, and availability under the revolving credit facility will be sufficient to satisfy the company's requirements for the next twelve months. The company anticipates spending more on capital expenditures in 2024 than in 2023.

Management Comments

• Management believes that synergies within the Branded Products segment will create opportunities to cross-sell products to new and existing customers.
• Management expects that demand for the company's signature marketing brands in the Healthcare Apparel segment will continue to provide opportunities for growth and increased market share.
• Management believes The Office Gurus is positioned well to continue growing its business in the Contact Centers segment.

Industry Context

The company operates in the branded products, healthcare apparel, and contact center industries. The report notes that the nearshore call-center market is growing, which is a positive trend for the company's Contact Centers segment. The company's performance is also affected by general economic conditions, including inflation and interest rate changes, which are impacting many businesses across various industries.

Comparison to Industry Standards

• The company's gross margin of 38.5% for the quarter is within the range of other apparel and promotional product companies, but specific comparisons are difficult without detailed competitor data.
• The company's interest expense reduction is a positive sign, especially compared to companies with higher debt burdens.
• The company's reported material weakness in internal controls is a concern, as it is not in line with best practices for public companies and may be a concern for investors.
• The company's performance in the contact center segment is in line with the industry trend of growth in nearshore outsourcing.

Legal Proceedings

• The company is involved in various legal actions and claims arising from the normal course of business, but management does not expect these to have a material impact.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and the material weakness in internal controls.
• Employees may be affected by the company's performance and any potential changes in operations.
• Customers may be impacted by any disruptions in the company's supply chain or service delivery.
• Creditors may be concerned about the company's debt levels and ability to meet its obligations.

Next Steps

• The company will continue to evaluate the Guardian liability for remeasurement at the end of each reporting period.
• The company will continue to monitor the effectiveness of its remediation plan for the material weakness in internal control over financial reporting.
• The company will continue to pay dividends in the future as financial conditions permit.

Key Dates

Keywords

financial results, net sales, net income, EBITDA, gross margin, operating expenses, interest expense, debt, credit facilities, internal control, share-based compensation, dividends, branded products, healthcare apparel, contact centers